About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about REGN

Recent news which mentions REGN

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
Tickers AAPL AMGN AMZN BKNG
Tags Federal Reserve DIA META
From Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Tickers ABBV AMGN BIIB BMY
Tags Expert Ideas General Biotech
From Benzinga
EyePoint's Investigational Drug Shows Early And Sustained Improvement Than Regeneron's Eylea For Diabetes-Associated Vision Loss
Tickers EYPT NEWS REGN
Tags Benzinga Movers Biotech
From Benzinga
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
Tickers AMGN CMG GS LLY
Tags LLY AMGN ROG
From Motley Fool
Eli Lilly's Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron's Dupixent
Tickers LLY NEWS REGN SNY
Tags Market News News Stories That Matter
From Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $5,800 Today
Tickers NEWS REGN
Tags News Market News Trading Ideas
From Benzinga
A Closer Look at 23 Analyst Recommendations For Regeneron Pharmaceuticals
Tickers REGN
Tags BZI/AAR Market News Benzinga
From Benzinga
Exploring The Competitive Space: Regeneron Pharmaceuticals Versus Industry Peers In Biotechnology
Tickers NEWS REGN
Tags Benzinga BZI/IA Markets
From Benzinga
Seagate To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Wednesday
Tickers MCD MCO NEWS NSC
Tags ZION STX Markets
From Benzinga
Market Whales and Their Recent Bets on REGN Options
Tickers REGN
Tags Markets BZI/UOA Benzinga
From Benzinga
Here's How Much $100 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth Today
Tickers NEWS REGN
Tags Benzinga News Market News
From Benzinga
What the Options Market Tells Us About Regeneron Pharmaceuticals
Tickers REGN
Tags Markets BZI/UOA Benzinga
From Benzinga
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
Tickers AMGN AZN BMRN GILD
Tags REGN GILD Briefs
From Benzinga
Inquiry Into Regeneron Pharmaceuticals's Competitor Dynamics In Biotechnology Industry
Tickers NEWS REGN
Tags Trading Ideas REGN Markets
From Benzinga
Regeneron Chief Flags Health Risks with Popular Weight-Loss Medications Like Ozempic, Says Company Targets Muscle Preservation For Its Obesity Drugs
Tickers LLY NEWS NVO REGN
Tags REGN Media Health Care
From Benzinga
Should You Buy the Dip on This Top Growth Stock?
Tickers AMGN REGN
Tags Market News REGN Recent Press Releases
From Motley Fool
A Closer Look at 24 Analyst Recommendations For Regeneron Pharmaceuticals
Tickers REGN
Tags Market News BZI/AAR Analyst Ratings
From Benzinga
Market Whales and Their Recent Bets on REGN Options
Tickers REGN
Tags Market News Options Markets
From Benzinga
(REGN) - Analyzing Regeneron Pharmaceuticals's Short Interest
Tickers REGN
Tags Short Ideas Market News Trading Ideas
From Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today
Tickers NEWS REGN
Tags News Market News BZI/POD
From Benzinga
Regeneron Pharma, Super Micro Computer And Global Payments Are Among Top 10 Large Cap Losers Last Week (Sept 23-Sept 27): Are The Others In Your Portfolio?
Tickers AFRM FCNCA FTI GPN
Tags MMYT Trading Ideas KNTK
From Benzinga
FDA Approves Regeneron/Sanofi's Blockbuster Dupixent For Smoker's Lung Disease
Tickers NEWS REGN SNY
Tags Trading Ideas FDA News
From Benzinga
Taiwan Semiconductor, American Tower, Trane Technologies And A Health Care Stock On CNBC's 'Final Trades'
Tickers AMGN AMT NEWS REGN
Tags TSM AMGN Amy Raskin
From Benzinga
A Closer Look at Regeneron Pharmaceuticals's Options Market Dynamics
Tickers REGN
Tags Markets REGN Benzinga
From Benzinga
Exploring The Competitive Space: Regeneron Pharmaceuticals Versus Industry Peers In Biotechnology
Tickers NEWS REGN
Tags Markets Trading Ideas REGN
From Benzinga
Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market
Tickers AMGN CGEM NEWS REGN
Tags why it's moving Health Care Briefs
From Benzinga
Why Is Regeneron Pharmaceuticals Stock Trading Lower On Tuesday?
Tickers AMGN NEWS REGN VTRS
Tags Legal AMGN News
From Benzinga
This BP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Tickers BIDU BP FHN MCK
Tags Pre/Market Outlook Downgrades REGN
From Benzinga
Smart Money Is Betting Big In REGN Options
Tickers REGN
Tags Market News Options Markets
From Benzinga
Competitor Analysis: Evaluating Regeneron Pharmaceuticals And Competitors In Biotechnology Industry
Tickers NEWS REGN
Tags Benzinga BZI/IA REGN
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.